With a modern-flavor on old-school house-calls, Dispatch Health provides Denver area residents a combined physician and EMT experience, all thru an easy to use app…. AND it takes many insurance. According to the Dispatch Health website, here is how it works:
You request care thru an app or website, where you explain your symptoms. You get immediately triaged while a team is dispatched. Then the team arrives, and you get treated. Read more at: https://www.dispatchhealth.com/
Today’s blog comes to us from Lithuania, where researchers at the Kaunas University of Technology institute of Biomedical Engineering are developing a bathroom scale that could detect life-threatening conditions.
In a news release, the researchers state that this scale will be able to not only monitor for such things as arteriosclerosis or cardiac arrhythmia, but ultimately 20 other parameters/conditions like hyperkalemia (elevated level of potassium in dialysis patients). Read more in this article on the KTU website: Bathroom Scales Will Inform About Life Threatening Conditions.
The University of Pittsburgh has released findings from two studies that may improve outcomes for the very serious and limited treatment options pancreatic cancer condition. In the first study, the researchers used genomic profiling to identify targeted therapies for the patients and in the other researchers used existing drugs that are used to treat similar genetic conditions.
Half of the patients who “received genomic-guided therapy experienced significant clinical benefit with improvement in overall survival.” Read more at the University of Pittsburgh website
In a press release from 5/9, Seattle Children’s Hospital has announced results from a phase 1 pilot study showing “T-cell immunotherapy to be effective in getting 93 percent of patients with relapsed or refractory acute lymphoblastic leukemia (ALL) into complete initial remission.”
This pilot, the Seattle Children’s Pediatric Leukemia Adoptive Therapy (PLAT-02) trial opens the door for a PLAT-03 trial, where patients will receive “booster” infusions of a second T-cell product, called T antigen-presenting cells (T-APCs). The hope of the next pilot is to help put patients in long-term remission. Read more at: Seattle Children’s Hospital Website.
In a report today from HealthcareITNews, we hear about Carolinas HealthCare taking a new approach to treatment, taking a cue from Amazon.
CHS is attempting to anticipate new technologies that can be quickly adopted in hopes that it would help them become the ” de facto standard of care and experience”. In this way, CHS has begun a number of programs. For example, for $49 CHS provides “live, 24-hour access to medical providers via camera-enabled smartphones, tablets or computers.”
According to the report this “service alone doesn’t make Carolinas the Amazon Prime of healthcare — but it helps Carolinas move in that direction.” Read more at: http://www.healthcareitnews.com/news/carolinas-chases-dream-becoming-healthcares-amazon-prime
According to the University of Alabama at Birmingham Department of Surgery, physicians have transplanted a cadaver liver that was “kept alive” outside the body and tested for function for 24 hours before it was transplanted. According to the UAB website: “UAB’s School of Medicine and UAB Hospital have joined 14 other transplant centers in the United States in this study. Research efforts like this clinical trial have focused on overcoming the limitations of cold storage, which is the current universal standard for organ preservation, with a move toward normothermic machine perfusion.” Read more at: http://www.uab.edu/news/innovation/item/8226